<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Rebsamen M</dc:creator>
  <dc:creator>Meylan E</dc:creator>
  <dc:creator>Curran J</dc:creator>
  <dc:creator>Tschopp J</dc:creator>
  <dc:date>2008</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The outcome of a viral infection depends on the interplay between the host's capacity to trigger potent antiviral responses and viral mechanisms that counteract them. Although Toll-like receptor (TLR)-3, which recognizes virally derived double-stranded (ds) RNA, transmits downstream antiviral signaling through the TIR adaptor Trif (TICAM-1), viral RNA-sensing RIG-like helicases (RLHs) use the mitochondrial-bound CARD protein Cardif (IPS-1/MAVS/VISA). The importance of these two antiviral signaling pathways is reflected by the fact that both adaptors are inhibited through specific cleavage triggered by the hepatitis C virus serine protease NS3-4A. Here, we show that inactivation can also occur through cellular caspases activated by various pro-apoptotic signals. Upon caspase-dependent cleavage both adaptors loose their capacity to activate the transcription factors interferon regulatory factors (IRF) and NF-kappaB. Importantly, poliovirus infection triggers a caspase-dependent cleavage of Cardif, suggesting that some viruses may activate caspases not only as a mean to facilitate shedding and replication, but also to impair antiviral responses.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/24763</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/cdd.2008.119</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/18756281</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Cell death and differentiation. - 2008</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adaptor Proteins, Signal Transducing</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adaptor Proteins, Vesicular Transport</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Antiviral Agents</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Caspases</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">HeLa Cells</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Interferon Regulatory Factors</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Models, Biological</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Poliovirus</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Protein Processing, Post-Translational</dc:subject>
  <dc:title xmlns:ns11="xml" ns11:lang="en">The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
